Heart Failure Congress 2013

Heart Failure 2013 Congress report
Authors: Mamas Mamas (Manchester, UK)
Hypervolaemia, heart rate, comorbidities, selection of patients for HF management and how to deal with class II recommendations discussed in light of optimising pharmacological management in HF.

As an online or full HFA member you have now access to two new modules on the ESC eLearing platform and can get four more CME credits:
- Diagnosis of Heart Failure
- How to use ACE inhibitors & ARBs in Heart Failure

Not yet an online or full member? Join the Heart Failure Association now

Heart Failure 2013 Congress report
Authors: Ulrich Laufs (Homburg, Germany)
U-shaped relation between risk factors and outcomes in HF suggests that deleterious effects can be observed at both ends of the spectrum, and further research is necessary to re-think common recommendations on risk factor management in CHF.

Heart Failure 2013 Congress Report
Authors: Rolf Wachter
Overview of the use of cardiac inotropes, identifying the indications and precautions for commonly prescribed molecules in this area, including digoxin, dobutamine, milrinone, levosimendan.